Chemclin Diagnostics Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 359.92 million compared to CNY 355.46 million a year ago. Revenue was CNY 359.92 million compared to CNY 355.46 million a year ago.

Net income was CNY 118.25 million compared to CNY 107.8 million a year ago. Basic earnings per share from continuing operations was CNY 0.29 compared to CNY 0.28 a year ago. Diluted earnings per share from continuing operations was CNY 0.29 compared to CNY 0.28 a year ago.